PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.\', \'Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.\', \'Biology of Cardiovascular Disease, INSERM, University of Bordeaux, U1034 Pessac, Bordeaux, France.\', \'College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada.\', \'Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.\', \'Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar. Fatima.Mraiche@qu.edu.qa.\', \'Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar. Fatima.Mraiche@qu.edu.qa.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11033-022-07183-w
?:doi
?:hasPublicationType
?:journal
  • Molecular biology reports
is ?:pmid of
?:pmid
?:pmid
  • 35102475
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.721
?:rankingScore_hIndex
  • 56
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35102475>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35102475>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all